Antiviral drugs that target reverse transcriptase

It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases

Antiviral drugs that target reverse transcriptase can block this process, effectively inhibiting HIV from replicating and spreading to new cells.

Antiviral drugs include protease inhibitors used to treat HIV/AIDS [109] and Hepatitis C, [110] reverse-transcriptase inhibitors targeting HIV/AIDS, [111] neuraminidase inhibitors targeting influenza, [112] and terminase inhibitors targeting human cytomegalovirus.

Reverse transcriptase of HIV as a target for anti-viral drugs. Reverse transcriptase of HIV as a target for anti-viral drugs. Antiviral Agents / pharmacology

Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) Nucleoside reverse transcriptase inhibitors (NRTIs), and nucleotide reverse transcriptase inhibitors (NtRTIs), often all referred to as NRTIs, work by targeting the action of an HIV protein called reverse transcriptase.

The reverse transcriptase activity of P is the target for the nucleos(t)ide analog drugs that dominate HBV treatment, and P is the target of ongoing efforts to develop new drugs against both the reverse transcriptase and ribonuclease H activities.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are antiviral agents that bind non-competitively to HIV-1's reverse transcriptase and prevents

Polymerase and Reverse Transcriptase Inhibitors; Some antiviral drugs target DNA or RNA polymerase to inhibit DNA/RNA replication, e.g, viral DNA polymerase inhibitors, like acyclovir and tenofovir. On the other hand, some drugs target the reverse transcriptase (RT) enzyme inhibiting the synthesis of DNA from RNA.

A non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the Not Available. Drugs Drug Targets. Drug, Target, Type. Nevirapine Cytochrome